User profiles for "author:Tatsuya Atsumi"
 | Tatsuya AtsumiHokkaido University Verified email at med.hokudai.ac.jp Cited by 29231 |
14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends
Current classification criteria for definite Antiphospholipid Syndrome (APS) require the use
of three laboratory assays to detect antiphospholipid antibodies (aCL, anti-β2GPI and LA) in …
of three laboratory assays to detect antiphospholipid antibodies (aCL, anti-β2GPI and LA) in …
[HTML][HTML] International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
New clinical, laboratory and experimental insights, since the 1999 publication of the
Sapporo preliminary classification criteria for antiphospholipid syndrome (APS), had been …
Sapporo preliminary classification criteria for antiphospholipid syndrome (APS), had been …
Development of a new international antiphospholipid syndrome classification criteria phase I/II report: generation and reduction of candidate criteria
Objective An international multidisciplinary initiative, jointly supported by the American
College of Rheumatology and European Alliance of Associations for Rheumatology, is …
College of Rheumatology and European Alliance of Associations for Rheumatology, is …
The 2023 ACR/EULAR antiphospholipid syndrome classification criteria
M Barbhaiya, S Zuily, R Naden, A Hendry… - Arthritis & …, 2023 - Wiley Online Library
Objective To develop new antiphospholipid syndrome (APS) classification criteria with high
specificity for use in observational studies and trials, jointly supported by the American …
specificity for use in observational studies and trials, jointly supported by the American …
Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis
R Koike, M Harigai, T Atsumi, K Amano… - Modern …, 2009 - academic.oup.com
The introduction of biological agents targeting tumor necrosis factor-alpha (TNF-α) has
brought about a paradigm shift in the treatment of rheumatoid arthritis (RA). Although these …
brought about a paradigm shift in the treatment of rheumatoid arthritis (RA). Although these …
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
Background A phase 2 trial of tocilizumab showed preliminary evidence of efficacy in
systemic sclerosis. We assessed skin fibrosis and systemic sclerosis-associated interstitial …
systemic sclerosis. We assessed skin fibrosis and systemic sclerosis-associated interstitial …
Association of autoantibodies against the phosphatidylserine–prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of …
T Atsumi, M Ieko, ML Bertolaccini… - … : Official Journal of …, 2000 - Wiley Online Library
Objective To clarify the association of autoantibodies against prothrombin with the clinical
manifestations of the antiphospholipid syndrome (APS) and with the presence of lupus …
manifestations of the antiphospholipid syndrome (APS) and with the presence of lupus …
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with …
D van der Heijde, JCC Wei, M Dougados, P Mease… - The Lancet, 2018 - thelancet.com
Background Biological disease-modifying anti-rheumatic drugs (bDMARDs) are
recommended for radiographic axial spondyloarthritis, otherwise known as ankylosing …
recommended for radiographic axial spondyloarthritis, otherwise known as ankylosing …
Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events
Objective To define the antiphospholipid score (aPL‐S) by testing multiple antiphospholipid
antibodies (aPL) and to evaluate its efficacy for the diagnosis of antiphospholipid syndrome …
antibodies (aPL) and to evaluate its efficacy for the diagnosis of antiphospholipid syndrome …
The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome
O Amengual, T Atsumi, MA Khamashta… - Thrombosis and …, 1998 - thieme-connect.com
The antiphospholipid syndrome (APS) is characterised by both arterial and venous
thrombosis, recurrent pregnancy loss and thrombocytopaenia in association with …
thrombosis, recurrent pregnancy loss and thrombocytopaenia in association with …